[1] 何彩华,曾祥兴.人乳头瘤病毒基因型检测及其人群分布特征[J].国际免疫学杂志,2014,37(6):549-553. [2] 鄢春晖,陈林,袁蔓莉等.重庆地区12196例妇科门诊患者HPV亚型感染情况分析[J].重庆医学,2014,43(35):4746-4748. [3] 邓健康,陈梦岚,郭晓兰等.四川省东北地区女性宫颈病变与感染人乳头瘤病毒基因型的关系[J].重庆医学,2014,43(36):4914-4916. [4] 汤福想,刘玉玲,王会娟等.妇女宫颈HPV感染及基因亚型分布[J].实用预防医学,2010,17(9):1717-1719. [5] Marais DJ, Sampson C, Jeftha A,et al.More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population[J].BMC Infectious Diseases,2006,6(1):95. [6] Chen WG, Yang CM, Xu LH,et al.Gene chip technology used in the detection of HPV infection in esophageal cancer of Kazakh Chinese in XinjiangProvince[J].J Huazhong Univ Sci Technolog Med Sci,2014,34(3):343-7. [7] 俞春松,江敏敏,刘小香等.浙江省嘉兴地区健康和宫颈病变妇女人乳头瘤病毒感染情况分析[J].中华实验和临床病毒学杂志,2014,28(5):339-341. [8] DENG Man-ling,邓曼玲,唐薇等.不同类型HPV与宫颈上皮内瘤变和宫颈癌的关系[J].实用预防医学,2010,17(8):1520-1522. [9] 李小欢,张春蕾,华正宇等.大连地区女性人乳头瘤病毒基因分型联合液基细胞学检测的临床应用[J].中国实验诊断学,2014,18(11):1790-1792. [10] 陈逸平,陈雪初,叶剑荣等.275株人乳头瘤病毒亚型分析[J].实用预防医学,2014,21(8):996-998. [11] Einstein MH, Baron M, Levin MJ, et al.Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years[J]. Hum Vaccin,2011, 7(12):1359-73.
2016, Vol. 23 
